Private Market View

Antithesis

Business/Productivity Software · Vienna, VA · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
$215.0M
Total raised
$160.0M
Last round
Later Stage VC (Series A)
Dec 2025

Key facts

  • Antithesis’s last known valuation is $215.0M (Feb 2024).
  • It has raised $160.0M across 2 recorded rounds; the latest was Later Stage VC (Series A) ($105.0M) in Dec 2025.
  • Notable investors include US National Science Foundation, Spark Capital, Amplify Partners, Teamworthy Group, Sovereign's Capital23 tracked in total.
  • 1 investment vehicle was formed to buy Antithesis shares in the last 12 months, reporting $106K sold to 2 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 23 names
  • ·Watchlist + deal alerts for Antithesis
Create free account
No card required

Funding rounds

2 rounds
Dec 2025Later Stage VC (Series A)$105.0M
Feb 2024Seed Round$47.0M

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Antithesis shares, reporting $106K sold to 2 investors. Most recent filing Mar 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle

About Antithesis

Developer of quality assurance software intended to facilitate autonomous software testing. The company's software searches for software bugs in a controlled environment where all bugs are reproducible and offer fault tolerance bugs, enabling clients to detect failures of their software that occur under specific network, hardware, or timing conditions.

Industry
Business/Productivity Software
Sector
Information Technology
HQ
Vienna, VA, United States
Founded
2018
Employees
91
Ownership
Privately Held (backing)
PA Mark — not yet priced

Antithesis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Antithesis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Antithesis in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.